RBC Initiates GE HealthCare at Outperform, $80 Target on AI Growth

RBC Capital Markets initiated coverage of GE HealthCare Technologies (ticker: GEHC) with an Outperform rating and an $80 price target, according to a report from Investing.com.

Rating Change

Prior to this initiation, RBC had no previous rating for GE HealthCare. The new rating is Outperform with a price target of $80, indicating expected performance above the market average.

Analyst Rationale

RBC analysts believe GE HealthCare's expanding portfolio of AI-enabled imaging, diagnostics, and healthcare software products positions the company for accelerated revenue and earnings growth over the next several years. They see the AI-led innovation cycle as a key growth driver.

Context

This coverage comes amid growing interest in AI healthcare solutions. GE HealthCare, which spun off from General Electric in January 2023, focuses on innovation in imaging and diagnostics. No other analyst ratings have been reported as significantly different at this time.

What to Make of It

RBC's recommendation reflects confidence in GE HealthCare's AI-driven strategy. However, investors should consider potential risks such as competition and regulatory challenges before making investment decisions.